Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus–Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy | Zendy

Constance A. Benson | Zendy; Janet W. Andersen | Zendy; Bernard Macatangay | Zendy; Robbie B. Mailliard | Zendy; Charles R. Rinaldo | Zendy; Sarah Read | Zendy; Dawn R. Bozzolo | Zendy; Lynette Purdue | Zendy; Cheryl Jennings | Zendy; Michael C. Keefer | Zendy; Marshall J. Glesby | Zendy; Pablo Tebas | Zendy; Amy Falk Russell | Zendy; Jason Martin | Zendy; Paula W. Annunziato | Zendy; Zoran Popmihajlov | Zendy; Jeffrey L. Lennox | Zendy

Open Access

Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus–Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy

Author(s) -

Constance A. Benson,

Janet W. Andersen,

Bernard Macatangay,

Robbie B. Mailliard,

Charles R. Rinaldo,

Sarah Read,

Dawn R. Bozzolo,

Lynette Purdue,

Cheryl Jennings,

Michael C. Keefer,

Marshall J. Glesby,

Pablo Tebas,

Amy Falk Russell,

Jason Martin,

Paula W. Annunziato,

Zoran Popmihajlov,

Jeffrey L. Lennox

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy242

Subject(s) - medicine , immunogenicity , placebo , adverse effect , immunology , titer , clinical endpoint , viral load , elispot , confidence interval , antibody titer , antibody , randomized controlled trial , virology , virus , immune system , t cell , pathology , alternative medicine

Herpes zoster (HZ) risk is increased in human immunodeficiency virus (HIV)-infected persons. Live attenuated zoster vaccine (ZV) reduces HZ incidence and severity in adults; safety and immunogenicity data in HIV-infected adults are limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research